EUVIMEDEUVIMED entdecken
Open Access

Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile

Jingdong Yang iD, Yuanyuan Qian, Choon Kim iD, Biruk T Birhanu iD, Carlos Cal Y Mayor-Luna, Derong Ding, Xiaotan Yu, Valerie A Schroeder, Shahriar Mobashery iD, Mayland Chang iD

Journal of Medicinal Chemistry · 08.05.2025 · 68 (9) · 9357-9370

DOI: 10.1021/acs.jmedchem.4c03090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.04.2025. Verfasst von Jingdong Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States. Hauptthemen laut MEDLINE: Clostridioides difficile, Spores, Bacterial, Bacterial Proteins, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile, a Gram-positive, spore-forming anaerobic bacterium, is a major healthcare threat. Its spores colonize the gut following dysbiosis caused by broad-spectrum antibiotics, remaining dormant until host's bile acid triggers germination into vegetative cells that produce toxins, leading to diarrhea, colitis, and potentially death. Current antibiotics to treat C. difficile infection target vegetative cells but not spore germination, a pivotal step in infection development. This study unveils 1,2,4-oxadiazoles as a novel class of spore germination inhibitors and delineates the structure-activity relationship. Screening of 120 oxadiazoles revealed compound 110 (IC50 = 14 ± 1 μM or 6.3 ± 0.4 μg/mL). Compound 110 targets mature SleC (Kd = 12 ± 1.0 μM) and CspB (Kd = 8.0 ± 1.0 μM) on spores, inhibiting their enzymatic activities, thus preventing spore germination. To our knowledge, compound 110 is the first reported spore germination inhibitor targeting SleC/CspB, offering a promising avenue for C. difficile therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileSpores, BacterialBacterial ProteinsAnti-Bacterial AgentsOxadiazolesStructure-Activity RelationshipMicrobial Sensitivity Tests

Substanzen

Bacterial ProteinsAnti-Bacterial AgentsOxadiazoles

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.

ORCID-Profile: Jingdong Yang, Choon Kim, Biruk T Birhanu, Shahriar Mobashery, Mayland Chang

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Yang, J., Qian, Y., Kim, C., Birhanu, B. T., Cal Y Mayor-Luna, C., Ding, D., Yu, X., Schroeder, V. A., Mobashery, S., & Chang, M. (2025). Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile. Journal of Medicinal Chemistry, 68(9), 9357-9370. https://doi.org/10.1021/acs.jmedchem.4c03090

Vancouver

Yang J, Qian Y, Kim C, Birhanu BT, Cal Y Mayor-Luna C, Ding D, et al. Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile. Journal of Medicinal Chemistry. 2025;68(9):9357-9370. doi:10.1021/acs.jmedchem.4c03090

BibTeX
@article{Yang2025,
  author = {Yang, Jingdong and Qian, Yuanyuan and Kim, Choon and Birhanu, Biruk T and Cal Y Mayor-Luna, Carlos and Ding, Derong and Yu, Xiaotan and Schroeder, Valerie A and Mobashery, Shahriar and Chang, Mayland},
  title = {Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {9},
  pages = {9357--9370},
  doi = {10.1021/acs.jmedchem.4c03090}
}
Kostenlos starten →